AddLife AB (publ) - Asset Resilience Ratio
AddLife AB (publ) (ALIF-B) has an Asset Resilience Ratio of 6.40% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore ALIF-B asset base for the complete picture of this company's asset base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2025)
This chart shows how AddLife AB (publ)'s Asset Resilience Ratio has changed over time. See ALIF-B net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down AddLife AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see AddLife AB (publ) (ALIF-B) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr813.00 Million | 6.4% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr813.00 Million | 6.40% |
Asset Resilience Insights
- Limited Liquidity: AddLife AB (publ) maintains only 6.40% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
AddLife AB (publ) Industry Peers by Asset Resilience Ratio
Compare AddLife AB (publ)'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hubei Huaqiang High-Tech Co. Ltd. A
SHG:688151 |
Medical Instruments & Supplies | 26.12% |
|
Pegavision
TW:6491 |
Medical Instruments & Supplies | 17.14% |
|
SWS Hemodialysis Care Co. Ltd. A
SHG:688410 |
Medical Instruments & Supplies | 38.45% |
|
Caina Technology Co. Ltd.
SHE:301122 |
Medical Instruments & Supplies | 19.74% |
|
IVF Hartmann Holding AG
SW:VBSN |
Medical Instruments & Supplies | 52.05% |
|
Dentium
KO:145720 |
Medical Instruments & Supplies | 1.23% |
|
Medeon Biodesign
TWO:6499 |
Medical Instruments & Supplies | 7.38% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
Annual Asset Resilience Ratio for AddLife AB (publ) (2016–2025)
The table below shows the annual Asset Resilience Ratio data for AddLife AB (publ).
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.40% | Skr813.00 Million ≈ $87.49 Million |
Skr12.71 Billion ≈ $1.37 Billion |
+3.86pp |
| 2024-12-31 | 2.54% | Skr331.00 Million ≈ $35.62 Million |
Skr13.05 Billion ≈ $1.40 Billion |
-0.20pp |
| 2023-12-31 | 2.74% | Skr349.00 Million ≈ $37.56 Million |
Skr12.74 Billion ≈ $1.37 Billion |
+0.58pp |
| 2022-12-31 | 2.16% | Skr282.00 Million ≈ $30.35 Million |
Skr13.06 Billion ≈ $1.41 Billion |
-0.97pp |
| 2021-12-31 | 3.13% | Skr331.70 Million ≈ $35.70 Million |
Skr10.60 Billion ≈ $1.14 Billion |
-1.83pp |
| 2020-12-31 | 4.96% | Skr205.80 Million ≈ $22.15 Million |
Skr4.15 Billion ≈ $446.56 Million |
+2.05pp |
| 2019-12-31 | 2.91% | Skr95.40 Million ≈ $10.27 Million |
Skr3.27 Billion ≈ $352.38 Million |
+0.80pp |
| 2018-12-31 | 2.11% | Skr56.30 Million ≈ $6.06 Million |
Skr2.67 Billion ≈ $287.10 Million |
+1.82pp |
| 2017-12-31 | 0.29% | Skr5.40 Million ≈ $581.13K |
Skr1.89 Billion ≈ $203.53 Million |
-0.65pp |
| 2016-12-31 | 0.93% | Skr14.70 Million ≈ $1.58 Million |
Skr1.58 Billion ≈ $169.68 Million |
-- |
About AddLife AB (publ)
AddLife AB (publ), together with its subsidiaries, provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates in two segments, Labtech and Medtech. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical resear… Read more